Key result
Adjuvant radiotherapy with a mean heart dose >2 Gy significantly reduced septal (12.0 to 9.6 dB; P<0.001) and posterior wall (12.8 to 11.3 dB; P=0.007) cyclic variation of integrated backscatter.
Why the study?
Does ultrasound tissue characterization using cyclic variation of integrated backscatter detect early radiotherapy-induced myocardial changes in patients with early-stage breast cancer?
Cohort (n=73)
Does ultrasound tissue characterization using cyclic variation of integrated backscatter detect early radiotherapy-induced myocardial changes in patients with early-stage breast cancer?
Ultrasound tissue characterization using cyclic variation of integrated backscatter can detect early, subclinical radiotherapy-induced myocardial changes before conventional left ventricular systolic function declines.
Answers are grounded in this paper and cite their sources.
CVIBS may flag early RT-related myocardial changes missed by standard echo metrics in breast cancer; leaves open its screening utility pending validation trials.
BACKGROUND: Increased cardiovascular morbidity and mortality are major late complications after radiotherapy (RT) in the thoracic region. Ultrasound tissue characterization (UTC) is a noninvasive method for the identification of myocardial changes. The aim of this prospective clinical trial was to assess whether the analysis of cyclic variation of integrated backscatter (CVIBS) can detect early RT-induced myocardial alterations. METHODS: Seventy-three eligible patients with early-stage breast cancer were evaluated before and immediately after adjuvant RT. Twenty and 53 patients had right-sided and left-sided breast cancer, respectively. None of the patients received chemotherapy. Comprehensive echocardiographic examination included three-dimensional (3D) measurements and UTC analysis of the left ventricular (LV) septum and posterior wall. RESULTS: RT reduced CVIBS in a dose-dependent manner. The mean heart radiation dose over two gray (Gy) reduced the septal CVIBS from 12.0±3.4 to 9.6±2.5 dB (P<.001) and the posterior wall CVIBS from 12.8±2.7 to 11.3±2.4 dB (P=.007). The CVIBS remained unchanged when the mean heart RT dose was below 2 Gy. Multivariate analysis showed an independent association with a change in septal CVIBS and the use of aromatase inhibitor (β=2.986, P=.001) and body mass index (β=-0.241, P=.014). The posterior values were worse with higher mean lung dose (β=-.485, P=.018) and with nonsmoking status (β=-2.411, P=.009). Echocardiography parameters showed increased myocardial mass but conventional measurements of the LV systolic function remained unchanged. CONCLUSIONS: Cyclic variation of integrated backscatter analysis seems to be a sensitive method to detect early RT-induced myocardial changes. Hence, it may be useful in screening of patients needing closer follow-up.
No takes yet. Share an insight, caveat, or question.
Tuohinen et al. (2017) conducted a cohort in Early-stage breast cancer (n=73). Adjuvant radiotherapy vs. Mean heart radiation dose < 2 Gy was evaluated on Cyclic variation of integrated backscatter (CVIBS) of the left ventricular septum and posterior wall (p=<.001). Adjuvant radiotherapy with a mean heart dose >2 Gy significantly reduced septal (12.0 to 9.6 dB; P<0.001) and posterior wall (12.8 to 11.3 dB; P=0.007) cyclic variation of integrated backscatter.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: